PlainRecalls
FDA Drug Moderate Class II Terminated

Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00

Reported: September 21, 2022 Initiated: September 15, 2022 #D-1538-2022

Product Description

Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00

Reason for Recall

Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.

Details

Recalling Firm
RemedyRepack Inc.
Units Affected
1,699 blister cards/30 tablets each
Distribution
Distributed to two direct accounts in PA and AK.
Location
Indiana, PA

Frequently Asked Questions

What product was recalled?
Lisinopril 10 mg tablets, 30-count Blister Card, Rx Only, MFG: Lupin Pharma, Baltimore, MD Repackaged by: RemedyRepack Inc, Indiana PA. Original NDC# 68180-0980-03, Repackaged NDC# 70518-0468-00. Recalled by RemedyRepack Inc.. Units affected: 1,699 blister cards/30 tablets each.
Why was this product recalled?
Presence of Foreign Substance: Foreign material (metal piece) embedded in one tablet.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 21, 2022. Severity: Moderate. Recall number: D-1538-2022.